Dr. Matt Evison from Manchester University Hospital NHS Trust speaks about the value of technological interventions and earlier diagnosis of symptomatic lung cancer, emphasising on the early diagnostic part of the lung cancer care pathway. Excerpts from UKIO 2022.
